Acamprosate Enrolling by Invitation Phase 2 Trials for Fragile X Syndrome (FXS) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02998151Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X Syndrome